Investigation of cytokine changes and deiminated proteins in LPS-induced inflammation in BV2 microglial cells

1 Kovacs GG. Concepts and classification of neurodegenerative diseases. Handb Clin Neurol, vol. 145, Elsevier; 2018, p. 301-7. DOI: 10.1016/B978-0-12-802395-2.00021-3 Search in Google Scholar

2 Neumann H, Kotter MR, Franklin RJM. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009;132:288-95. DOI: 10.1093/brain/awn109 Search in Google Scholar

3 Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol 2014;32:367-402. DOI: 10.1146/annurev-immunol-032713-120240 Search in Google Scholar

4 Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer’s disease. Biol Psychiatry 2010;68:930-41. DOI: 10.1016/j. biopsych.2010.06.012 Search in Google Scholar

5 Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Neurol 2016;73:1316-24. DOI: 10.1001/jamaneurol.2016.2742 Search in Google Scholar

6 Li X, Zhou JX, Qu YD, Kuang X. Сyclooxygenase-2 Inhibitor Parecoxib Reduces LPS-Induced Activation of BV2 Microglia Cells. Bull Exp Biol Med 2023:1-6. DOI: 10.1007/s10517-024-06012-3 Search in Google Scholar

7 Oeckl P, Steinacker P, von Arnim CA, Straub S, Nagl M, Feneberg E, et al. Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer’s disease and frontotemporal lobar degeneration. J Proteome Res 2014;13:4518-25. DOI: 10.1021/pr5006058 Search in Google Scholar

8 Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni MG. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci 2014;8:380. DOI: 10.3389/fncel.2014.00380 Search in Google Scholar

9 Nam HY, Nam JH, Yoon G, Lee JY, Nam Y, Kang HJ, et al. Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. J Neuroinflammation 2018;15:271. DOI: 10.1186/s12974-018-1308-0 Search in Google Scholar

10 Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003;25:1106-18. DOI: 10.1002/bies.10357 Search in Google Scholar

11 Inal JM, Hristova M, Lange S. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species. Int J Mol Sci 2022;23:8697. DOI: 10.3390/ijms23158697 Search in Google Scholar

12 Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol 2011;48:1592-603. DOI: 10.1016/j. molimm.2011.04.003 Search in Google Scholar

13 Magnadottir B, Hayes P, Gisladottir B, Bragason Bt, Hristova M, Nicholas AP, et al. Pentraxins CRP-I and CRP-II are post-translationally deiminated and differ in tissue specificity in cod (Gadus morhua L.) ontogeny. Dev Comp Immunol 2018;87:1-11. DOI: 10.1016/j.dci.2018.05.014 Search in Google Scholar

14 Braig D, Nero TL, Koch HG, Kaiser B, Wang X, Thiele JR, et al. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun 2017;8:14188. DOI: 10.1038/ncomms14188 Search in Google Scholar

15 Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, et al. Increased CSF biomarkers of angiogenesis in Parkinson disease. Neurology 2015;85:1834-42. DOI: 10.1212/WNL.0000000000002151 Search in Google Scholar

16 Nicholas AP. Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci Lett 2011;495:26-9. DOI: 10.1016/j.neulet.2011.03.028 Search in Google Scholar

17 Tai Y, Qiu Y, Bao Z. Magnesium Lithospermate B Suppresses Lipopolysaccharide-Induced Neuroinflammation in BV2 Microglial Cells and Attenuates Neurodegeneration in Lipopolysaccharide-Injected Mice. J Mol Neurosci 2018;64:80-92. DOI: 10.1007/s12031-017-1007-9 Search in Google Scholar

18 Sun Y, Gao L, Hou W, Wu J. beta-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-kappaB Pathways in LPS-Exposed BV2 Cells. Biomed Res Int 2020;2020:7532306. DOI: 10.1155/2020/7532306 Search in Google Scholar

19 Qin Y, Qiu J, Wang P, Liu J, Zhao Y, Jiang F, et al. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson’s disease. Brain Behav Immun 2021;91:324-38. DOI: 10.1016/j.bbi.2020.10.010 Search in Google Scholar

20 Nguyen PL, Bui BP, Duong MTH, Lee K, Ahn H-C, Cho J. Suppression of LPS-induced inflammation and cell migration by azelastine through inhibition of JNK/NF-κB pathway in BV2 microglial cells. Int J Mol Sci 2021;22:9061. DOI: 10.3390/ijms22169061 Search in Google Scholar

21 Kaneko N, Kudo K, Mabuchi T, Takemoto K, Fujimaki K, Wati H, et al. Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 2006;31:2619-26. DOI: 10.1038/sj.npp.1301137 Search in Google Scholar

22 Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005;5:526-42. DOI: 10.1038/nrc1649 Search in Google Scholar

23 Witalison EE, Thompson PR, Hofseth LJ. Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation. Curr Drug Targets 2015;16:700-10. DOI: 10.2174/1389450116666150202160954 Search in Google Scholar

24 Nicholas AP, Lu L, Heaven M, Kadish I, van Groen T, Accaviti-Loper MA, et al. Ongoing studies of deimination in neurodegenerative diseases using the F95 antibody. Protein Deimination in Human Health and Disease 2014:257-80. DOI: 10.1007/978-1-4614-8317-5_14 Search in Google Scholar

25 Sancandi M, Uysal-Onganer P, Kraev I, Mercer A, Lange S. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease. Int J Mol Sci 2020;21:2743. DOI: 10.3390/ijms21082743 Search in Google Scholar

26 Ishigami A, Choi EK, Kim YS, Maruyama N. Deimination in Alzheimer’s disease. Protein Deimination in Human Health and Disease 2014:237-55. DOI: 10.1007/978-1-4614-8317-5_13 Search in Google Scholar

27 DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegeneration 14: 32 2019. DOI: 10.1186/s13024-019-0333-5 Search in Google Scholar

28 Nicholas AP. Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex. Neurosci Lett 2013;545:107-11. DOI: 10.1016/j.neulet.2013.04.028. DOI: 10.1016/j.neulet.2013.04.028 Search in Google Scholar

29 Morgan AR, Touchard S, Leckey C, O’Hagan C, Nevado-Holgado AJ, Consortium N, et al. Inflammatory biomarkers in Alzheimer’s disease plasma. Alzheimers Dement 2019;15:776-87. DOI: 10.1016/j.jalz.2019.03.007 Search in Google Scholar

30 Jang B, Ishigami A, Maruyama N, Carp RI, Kim YS, Choi EK. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration. Prion 2013;7:42-6. DOI: 10.4161/pri.22380 Search in Google Scholar

31 Witcher KG, Bray CE, Dziabis JE, McKim DB, Benner BN, Rowe RK, et al. Traumatic brain injury-induced neuronal damage in the somatosensory cortex causes formation of rod-shaped microglia that promote astrogliosis and persistent neuroinflammation. Glia 2018;66:2719-36. DOI: 10.1002/glia.23523 Search in Google Scholar

32 Jang B, Jin JK, Jeon YC, Cho HJ, Ishigami A, Choi KC, et al. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2010;119:199-210. DOI: 10.1007/s00401-009-0625-x Search in Google Scholar

33 Asaga H, Nakashima K, Senshu T, Ishigami A, Yamada, M. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukoc Biol 2001;70:46-51. DOI: 10.1189/jlb.70.1.46 Search in Google Scholar